Characterization of invasive Haemophilus influenzae disease in Manitoba, Canada, 2000-2006: invasive disease due to non-type b strains.
In addition to the proportional increase in cases of non-type b Haemophilus influenzae disease in the post-H. influenzae type b vaccine era, the incidence of invasive H. influenzae disease was found to be approaching the rates of H. influenzae type b disease that were documented in the prevaccine period. Fifty-six percent of invasive disease now occurs in individuals aged >10 years.
Tsang
Raymond S W
RS
Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada. raymond_tsang@phac-aspc.gc.ca
Sill
Michelle L
ML
Skinner
Stuart J
SJ
Law
Dennis K S
DK
Zhou
Jianwei
J
Wylie
John
J
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D021821:Communicable Diseases, Emerging / Q000145:classification / Q000453:epidemiology; D016021:Epidemiologic Studies; D005260:Female; D006192:Haemophilus Infections / Q000453:epidemiology*; D018073:Haemophilus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D006193:Haemophilus influenzae / Q000145:classification* / Q000472:pathogenicity; D019741:Haemophilus influenzae type b / Q000472:pathogenicity*; D006801:Humans; D015994:Incidence; D007223:Infant; D008297:Male; D008350:Manitoba / Q000453:epidemiology; D008875:Middle Aged; D010865:Pilot Projects; D015995:Prevalence; D012189:Retrospective Studies; D018571:Sentinel Surveillance
D018073:Haemophilus Vaccines